Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7126 AL 7140

Toxin-Induced Experimental Models of Learning and Memory Impairment

More SV, Kumar H, Cho DY, Yun YS, Choi DK.

Int J Mol Sci. 2016 Sep 1;17(9):1447. doi: 10.3390/ijms17091447.

Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease

Jiang T, Sun Q, Chen S.

Prog Neurobiol. 2016 Dec;147:1-19. doi: 10.1016/j.pneurobio.2016.07.005. Epub 2016 Oct 18.

Psychotropic Drug Development Strategies that Target Neuropsychiatric Etiologies in Alzheimer's and Parkinson's Diseases

Van der Schyf CJ.

Drug Dev Res. 2016 Dec;77(8):458-468. doi: 10.1002/ddr.21368. Epub 2016 Nov 4.

Comorbid conditions associated with Parkinson's disease: A longitudinal and comparative study with Alzheimer disease and control subjects

Santos García D, Suárez Castro E, Expósito I, de Deus T, Tuñas C, Aneiros A, López Fernández M, Núñez Arias D, Bermúdez Torres M.

J Neurol Sci. 2017 Feb 15;373:210-215. doi: 10.1016/j.jns.2016.12.046. Epub 2016 Dec 29.

Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics

Belaidi AA, Bush AI.

J Neurochem. 2016 Oct;139 Suppl 1:179-197. doi: 10.1111/jnc.13425. Epub 2016 Feb 10.

Endocannabinoid System in Neurological Disorders

Ranieri R, Laezza C, Bifulco M, Marasco D, Malfitano AM.

Recent Pat CNS Drug Discov. 2016;10(2):90-112. doi: 10.2174/1574889810999160719105433.

[A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy]

Pupyshev AB, Korolenko TA, Tikhonova MA.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2016 Sep;66(5):515-540.

Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders?

Jodeiri Farshbaf M, Ghaedi K.

Biometals. 2017 Feb;30(1):1-16. doi: 10.1007/s10534-016-9981-x. Epub 2016 Nov 16.

The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review

Manoharan S, Guillemin GJ, Abiramasundari RS, Essa MM, Akbar M, Akbar MD.

Oxid Med Cell Longev. 2016;2016:8590578. doi: 10.1155/2016/8590578. Epub 2016 Dec 27.

The use of pharmacological retromer chaperones in Alzheimer's disease and other endosomal-related disorders

Berman DE, Ringe D, Petsko GA, Small SA.

Neurotherapeutics. 2015 Jan;12(1):12-8. doi: 10.1007/s13311-014-0321-y.

Oxidative stress and neurodegenerative diseases: looking for a therapeutic solution inspired on benzopyran chemistry

Gaspar A, Milhazes N, Santana L, Uriarte E, Borges F, Matos MJ.

Curr Top Med Chem. 2015;15(5):432-45.

Retromer in Alzheimer disease, Parkinson disease and other neurological disorders

Small SA, Petsko GA.

Nat Rev Neurosci. 2015 Mar;16(3):126-32. doi: 10.1038/nrn3896. Epub 2015 Feb 11.

Compromised MAPK signaling in human diseases: an update

Kim EK, Choi EJ.

Arch Toxicol. 2015 Jun;89(6):867-82. doi: 10.1007/s00204-015-1472-2. Epub 2015 Feb 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias